Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders
- PMID: 15172939
- DOI: 10.1192/bjp.184.6.470
Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders
Abstract
Background: General practitioners play a pivotal part in the recognition and treatment of psychiatric disorders. Identifying somatoform disorders is important for the choice of treatment.
Aims: To quantify the prevalence of, and functional impairment associated with, somatoform disorders, and their comorbidity with anxiety/depressive disorders.
Method: Two-stage prevalence study: a set of questionnaires was completed by 1046 consecutive patients of general practitioners (aged 25-80 years), followed by a standardised diagnostic interview (SCAN 2.1).
Results: The prevalence of somatoform disorders was 16.1% (95% CI 12.8-19.4). When disorders with only mild impairment were included, the prevalence increased to 21.9%. Comorbidity of somatoform disorders and anxiety/depressive disorders was 3.3 times more likely than expected by chance. In patients with comorbid disorders, physical symptoms, depressive symptoms and functional limitations were additive.
Conclusions: Our findings underline the importance of a comprehensive diagnostic approach to psychiatric disorders in general practice.
Comment in
-
Somatoform disorders: a help or hindrance to good patient care?Br J Psychiatry. 2004 Jun;184:465-7. doi: 10.1192/bjp.184.6.465. Br J Psychiatry. 2004. PMID: 15172937 No abstract available.
